NVAXbenzinga

Novavax Confirms That April 1, 2025, Was The U.S. FDA's Prescription Drug User Fee Act Date For It's Biologics License Application Seeking The Approval Its COVID-19 Vaccine

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 2, 2025 by benzinga